Identification of differential PI3K pathway target dependencies in T-cell acute lymphoblastic leukemia through a large cancer cell panel screen

Name: Work Video:
Duration: 3 min 30 s
James T. Lynch; Robert McEwen; Claire Crafter; Ultan McDermott; Mathew J. Garnett; Simon T. Barry; Barry R. Davies
{'id': 'https://openalex.org/W2305721882', 'doi': 'https://doi.org/10.18632/oncotarget.8031', 'title': 'Identification of differential PI3K pathway target dependencies in T-cell acute lymphoblastic leukemia through a large cancer cell panel screen', 'display_name': 'Identification of differential PI3K pathway target dependencies in T-cell acute lymphoblastic leukemia through a large cancer cell panel screen', 'publication_year': 2016, 'publication_date': '2016-03-10', 'ids': {'openalex': 'https://openalex.org/W2305721882', 'doi': 'https://doi.org/10.18632/oncotarget.8031', 'mag': '2305721882', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/26989080', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/5008349'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.18632/oncotarget.8031', 'pdf_url': 'http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=8031&path%5B%5D=23594', 'source': {'id': 'https://openalex.org/S126644158', 'display_name': 'Oncotarget', 'issn_l': '1949-2553', 'issn': ['1949-2553'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316297', 'host_organization_name': 'Impact Journals LLC', 'host_organization_lineage': ['https://openalex.org/P4310316297'], 'host_organization_lineage_names': ['Impact Journals LLC'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'gold', 'oa_url': 'http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=8031&path%5B%5D=23594', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5020263332', 'display_name': 'James T. Lynch', 'orcid': 'https://orcid.org/0009-0002-8260-5355'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'James T. Lynch', 'raw_affiliation_strings': ['Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom'], 'affiliations': [{'raw_affiliation_string': 'Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5009167161', 'display_name': 'Robert McEwen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Robert McEwen', 'raw_affiliation_strings': ['Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom'], 'affiliations': [{'raw_affiliation_string': 'Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058325442', 'display_name': 'Claire Crafter', 'orcid': 'https://orcid.org/0000-0001-6566-0868'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Claire Crafter', 'raw_affiliation_strings': ['Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom'], 'affiliations': [{'raw_affiliation_string': 'Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5080415325', 'display_name': 'Ultan McDermott', 'orcid': 'https://orcid.org/0000-0001-9032-4700'}, 'institutions': [{'id': 'https://openalex.org/I2802476451', 'display_name': 'Wellcome Sanger Institute', 'ror': 'https://ror.org/05cy4wa09', 'country_code': 'GB', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I2802476451', 'https://openalex.org/I87048295']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Ultan McDermott', 'raw_affiliation_strings': ['Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, United Kingdom'], 'affiliations': [{'raw_affiliation_string': 'Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, United Kingdom', 'institution_ids': ['https://openalex.org/I2802476451']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085472676', 'display_name': 'Mathew J. Garnett', 'orcid': 'https://orcid.org/0000-0002-2618-4237'}, 'institutions': [{'id': 'https://openalex.org/I2802476451', 'display_name': 'Wellcome Sanger Institute', 'ror': 'https://ror.org/05cy4wa09', 'country_code': 'GB', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I2802476451', 'https://openalex.org/I87048295']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Mathew J. Garnett', 'raw_affiliation_strings': ['Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, United Kingdom'], 'affiliations': [{'raw_affiliation_string': 'Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, United Kingdom', 'institution_ids': ['https://openalex.org/I2802476451']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044054725', 'display_name': 'Simon T. Barry', 'orcid': 'https://orcid.org/0000-0002-8511-0588'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Simon T. Barry', 'raw_affiliation_strings': ['Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom'], 'affiliations': [{'raw_affiliation_string': 'Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5000275517', 'display_name': 'Barry R. Davies', 'orcid': 'https://orcid.org/0000-0002-5414-9113'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Barry R. Davies', 'raw_affiliation_strings': ['Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom'], 'affiliations': [{'raw_affiliation_string': 'Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom', 'institution_ids': ['https://openalex.org/I105036370']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.624, 'has_fulltext': False, 'cited_by_count': 23, 'citation_normalized_percentile': {'value': 0.89845, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 92, 'max': 93}, 'biblio': {'volume': '7', 'issue': '16', 'first_page': '22128', 'last_page': '22139'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10952', 'display_name': 'PI3K/AKT/mTOR signaling in cancer', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12534', 'display_name': 'Protein Degradation and Inhibitors', 'score': 0.9912, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/identification', 'display_name': 'Identification', 'score': 0.56091535}], 'concepts': [{'id': 'https://openalex.org/C2909962599', 'wikidata': 'https://www.wikidata.org/wiki/Q180664', 'display_name': 'Lymphoblastic Leukemia', 'level': 3, 'score': 0.6449738}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.6151129}, {'id': 'https://openalex.org/C116834253', 'wikidata': 'https://www.wikidata.org/wiki/Q2039217', 'display_name': 'Identification (biology)', 'level': 2, 'score': 0.56091535}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.516243}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5159981}, {'id': 'https://openalex.org/C86554907', 'wikidata': 'https://www.wikidata.org/wiki/Q285613', 'display_name': 'PI3K/AKT/mTOR pathway', 'level': 3, 'score': 0.50068617}, {'id': 'https://openalex.org/C2778461978', 'wikidata': 'https://www.wikidata.org/wiki/Q29496', 'display_name': 'Leukemia', 'level': 2, 'score': 0.44832295}, {'id': 'https://openalex.org/C1491633281', 'wikidata': 'https://www.wikidata.org/wiki/Q7868', 'display_name': 'Cell', 'level': 2, 'score': 0.43055743}, {'id': 'https://openalex.org/C70721500', 'wikidata': 'https://www.wikidata.org/wiki/Q177005', 'display_name': 'Computational biology', 'level': 1, 'score': 0.37516958}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.30018574}, {'id': 'https://openalex.org/C62478195', 'wikidata': 'https://www.wikidata.org/wiki/Q828130', 'display_name': 'Signal transduction', 'level': 2, 'score': 0.28953373}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.22696501}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.19781798}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.18881208}, {'id': 'https://openalex.org/C59822182', 'wikidata': 'https://www.wikidata.org/wiki/Q441', 'display_name': 'Botany', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000081082', 'descriptor_name': 'Phosphoinositide-3 Kinase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D054218', 'descriptor_name': 'Precursor T-Cell Lymphoblastic Leukemia-Lymphoma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D045744', 'descriptor_name': 'Cell Line, Tumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004354', 'descriptor_name': 'Drug Screening Assays, Antitumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004354', 'descriptor_name': 'Drug Screening Assays, Antitumor', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.18632/oncotarget.8031', 'pdf_url': 'http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=8031&path%5B%5D=23594', 'source': {'id': 'https://openalex.org/S126644158', 'display_name': 'Oncotarget', 'issn_l': '1949-2553', 'issn': ['1949-2553'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316297', 'host_organization_name': 'Impact Journals LLC', 'host_organization_lineage': ['https://openalex.org/P4310316297'], 'host_organization_lineage_names': ['Impact Journals LLC'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc5008349', 'pdf_url': 'https://europepmc.org/articles/pmc5008349?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008349', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/26989080', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.18632/oncotarget.8031', 'pdf_url': 'http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=8031&path%5B%5D=23594', 'source': {'id': 'https://openalex.org/S126644158', 'display_name': 'Oncotarget', 'issn_l': '1949-2553', 'issn': ['1949-2553'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316297', 'host_organization_name': 'Impact Journals LLC', 'host_organization_lineage': ['https://openalex.org/P4310316297'], 'host_organization_lineage_names': ['Impact Journals LLC'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.83, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 45, 'referenced_works': ['https://openalex.org/W1569244981', 'https://openalex.org/W1873528488', 'https://openalex.org/W1966133006', 'https://openalex.org/W1977137596', 'https://openalex.org/W1981711832', 'https://openalex.org/W2000589976', 'https://openalex.org/W2003560510', 'https://openalex.org/W2003677868', 'https://openalex.org/W2006613419', 'https://openalex.org/W2007240193', 'https://openalex.org/W2014673454', 'https://openalex.org/W2022379527', 'https://openalex.org/W2029754521', 'https://openalex.org/W2035943570', 'https://openalex.org/W2039160810', 'https://openalex.org/W2049396238', 'https://openalex.org/W2052273633', 'https://openalex.org/W2052763184', 'https://openalex.org/W2071463092', 'https://openalex.org/W2077173862', 'https://openalex.org/W2082416335', 'https://openalex.org/W2087693130', 'https://openalex.org/W2087976775', 'https://openalex.org/W2097360283', 'https://openalex.org/W2104684296', 'https://openalex.org/W2104692438', 'https://openalex.org/W2106933841', 'https://openalex.org/W2108068107', 'https://openalex.org/W2108752981', 'https://openalex.org/W2108846496', 'https://openalex.org/W2117497402', 'https://openalex.org/W2118151336', 'https://openalex.org/W2121216406', 'https://openalex.org/W2122825543', 'https://openalex.org/W2125789330', 'https://openalex.org/W2126839635', 'https://openalex.org/W2134831715', 'https://openalex.org/W2143112776', 'https://openalex.org/W2145722025', 'https://openalex.org/W2146414563', 'https://openalex.org/W2153096480', 'https://openalex.org/W2167009545', 'https://openalex.org/W2273553573', 'https://openalex.org/W2582743722', 'https://openalex.org/W4294541781'], 'related_works': ['https://openalex.org/W4385441962', 'https://openalex.org/W4220837694', 'https://openalex.org/W3188367623', 'https://openalex.org/W2898511335', 'https://openalex.org/W2031281657', 'https://openalex.org/W2011424260', 'https://openalex.org/W1978608178', 'https://openalex.org/W1974250949', 'https://openalex.org/W155856152', 'https://openalex.org/W1006589974'], 'abstract_inverted_index': {'//': [0], 'James': [1, 60], 'T.': [2, 24, 61], 'Lynch': [3], '1': [4, 8, 12, 26, 31, 32], ',': [5, 9, 13, 17, 22, 27], 'Robert': [6], 'McEwen': [7], 'Claire': [10], 'Crafter': [11], 'Ultan': [14], 'McDermott': [15], '2': [16, 21, 43], 'Mathew': [18], 'J.': [19], 'Garnett': [20], 'Simon': [23], 'Barry': [25, 28], 'R.': [29], 'Davies': [30], 'Oncology': [33], 'iMED,': [34], 'AstraZeneca,': [35], 'Alderley': [36], 'Park,': [37], 'Macclesfield,': [38], 'SK10': [39], '4TG,': [40], 'United': [41, 56], 'Kingdom': [42, 57], 'Wellcome': [44, 48], 'Trust': [45, 49], 'Sanger': [46], 'Institute,': [47], 'Genome': [50], 'Campus,': [51], 'Hinxton,': [52], 'Cambridgeshire,': [53], 'CB10': [54], '1SA,': [55], 'Correspondence': [58], 'to:': [59], 'Lynch,': [62], 'e-mail:': [63], '[email protected]': [64], 'Keywords:': [65], 'PI3K,': [66], 'AKT,': [67], 'mTOR,': [68], 'Notch,': [69], 'leukemia': [70, 155], 'Received:': [71], 'November': [72], '16,': [73], '2015': [74], 'Accepted:': [75], 'February': [76], '18,': [77], '2016': [78, 82], 'Published:': [79], 'March': [80], '10,': [81], 'ABSTRACT': [83], 'Selective': [84], 'phosphoinositide': [85], '3-kinase': [86], '(PI3K)/AKT/mTOR': [87], 'inhibitors': [88, 106], 'are': [89, 101], 'currently': [90], 'under': [91], 'evaluation': [92], 'in': [93, 151, 196, 226, 240], 'clinical': [94], 'studies.': [95], 'To': [96], 'identify': [97], 'tumor': [98], 'types': [99], 'that': [100, 136, 159, 179, 214], 'sensitive': [102, 138, 167], 'to': [103, 139, 168, 177, 221], 'PI3K': [104, 182], 'pathway': [105, 229], 'we': [107, 211], 'screened': [108], 'compounds': [109], 'targeting': [110], 'PI3Kα/δ': [111], '(AZD8835),': [112], 'PI3Kβ/δ': [113], '(AZD8186),': [114], 'AKT': [115, 140, 169, 232], '(AZD5363)': [116], 'and': [117, 141, 170, 203, 230], 'mTORC1/2': [118, 171], '(AZD2014)': [119], 'against': [120], 'a': [121, 237], 'cancer': [122], 'cell': [123, 127, 164, 197, 216], 'line': [124], 'panel': [125], '(971': [126], 'lines).': [128], 'There': [129], 'was': [130], 'an': [131], 'enrichment': [132], 'of': [133, 148, 189, 206], 'hematological': [134], 'malignancies': [135], 'were': [137, 166], 'mTOR': [142, 234], 'inhibition,': [143], 'with': [144, 173, 199], 'the': [145, 181, 227], 'greatest': [146], 'degree': [147], 'sensitivity': [149, 176, 220], 'observed': [150], 'T-cell': [152], 'acute': [153], 'lymphoblastic': [154], '(T-ALL).': [156], 'We': [157], 'found': [158], 'all': [160], 'NOTCH': [161], 'mutant': [162], 'T-ALL': [163, 215], 'lines': [165, 198, 217], 'inhibitors,': [172], 'only': [174, 191], 'partial': [175], 'agents': [178], 'target': [180], 'α,': [183], 'β': [184], 'or': [185, 233], 'δ': [186], 'isoforms.': [187], 'Induction': [188], 'apoptosis': [190], 'occurred': [192], 'following': [193], 'AKTi': [194], 'treatment': [195], 'PTEN': [200], 'protein': [201], 'loss': [202], 'high': [204], 'levels': [205], 'active': [207], 'AKT.': [208], 'In': [209], 'summary,': [210], 'have': [212, 236], 'demonstrated': [213], 'show': [218], 'differential': [219], 'inhibition': [222], 'at': [223], 'different': [224], 'nodes': [225], 'PI3K/AKT/mTOR': [228], 'inhibiting': [231], 'may': [235], 'therapeutic': [238], 'benefit': [239], 'this': [241], 'disease': [242], 'setting.': [243]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2305721882', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 5}, {'year': 2020, 'cited_by_count': 7}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 2}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 1}], 'updated_date': '2024-12-12T23:39:41.420565', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
